Ligand profile
0G4
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_32224 — DNA polymerase IV
Identifiers
Database identifiers and provenance.
- Ligand ID
0G4- PDB
4qw9- UniProt (similar protein)
Q97W02- Target protein
- KP13_32224
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 232.8
- −1 ≤ LogP ≤ 5 -0.53
- MW ≤ 500 Da 486.2
- LogP ≤ 5 -0.53
- H-bond donors ≤ 5 6
- H-bond acceptors ≤ 10 11
- Rotatable bonds ≤ 10 8
- TPSA ≤ 140 Ų 232.8
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C1[C@H](O[C@H](S1)COP(=O)(O)OP(=O)(NP(=O)(O)O)O)N2C=C(C(=NC2=O)N)FC1[C@H](O[C@H](S1)COP(=O)(O)OP(=O)(NP(=O)(O)O)O)N2C=C(C(=NC2=O)N)F
InChI=1S/C8H14FN4O11P3S/c9-4-1-13(8(14)11-7(4)10)5-3-28-6(23-5)2-22-27(20,21)24-26(18,19)12-25(15,16)17/h1,5-6H,2-3H2,(H,20,21)(H2,10,11,14)(H4,12,15,16,17,18,19)/t5-,6+/m0/s1InChI=1S/C8H14FN4O11P3S/c9-4-1-13(8(14)11-7(4)10)5-3-28-6(23-5)2-22-27(20,21)24-26(18,19)12-25(15,16)17/h1,5-6H,2-3H2,(H,20,21)(H2,10,11,14)(H4,12,15,16,17,18,19)/t5-,6+/m0/s1
LBSQECIRXSOKHJ-NTSWFWBYSA-NLBSQECIRXSOKHJ-NTSWFWBYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00817
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand 0G4 →
- PDB RCSB structure 4qw9 →
- UniProt UniProt Q97W02 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “0G4”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_32224.
PDB 31
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 3
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).